3 ms·
To paraphrase a drug development chemist (see https://blogs.sciencemag.org/pipeline/archives/2019/09/25/whats-crucial-and-what-isnt https://blogs.sciencemag.org
by jcranmer 5y ago
To paraphrase a drug development chemist (see https://blogs.sciencemag.org/pipeline/archives/2019/09/25/whats-crucial-and-what-isnt https://blogs.sciencemag.org/pipeline/archives/2019/09/25/wh...)...
No, it won't. Protein structure determination isn't exactly a rate-limiting step in drug development, especially since the computational chemistry models of binding aren't up to snuff when it comes to being substitutable for time-consuming animal models.
This press release and upselling of the protein structure determination advancements is a lot like the human genome project; while it was incredibly useful in its own right, everyone who predicted that it would unleash improvements in human health has been proved woefully wrong.
- moyix 5y agoI have already seen reports from biologists about AlphaFold solving protein structures that have resisted laboratory methods for decades [1,2]. It's hard for me to see why this is not a transformative development for (one part of) basic biology. Note that the BBC article doesn't actually say that it will transform drug discovery! I know HN is inclined to be cynical about big claims, but it is not hard to find computational biologists (unaffiliated with DeepMind) saying that this is indeed a revolutionary advance for biology: * Mohammed AlQuraishi, a computational biologist at Columbia University in New York City and a CASP participant [...]’s strong hunch is that AlphaFold will be transformational. * “It’s a game changer,” says Andrei Lupas, an evolutionary biologist at the Max Planck Institute for Developmental Biology in Tübingen, Germany, who assessed the performance of different teams in CASP. [...] “This will change medicine. It will change research. It will change bioengineering. It will change everything,” Lupas adds. [1] "An AlphaFold prediction helped to determine the structure of a bacterial protein that Lupas’s lab has been trying to crack for years. Lupas’s team had previously collected raw X-ray diffraction data, but transforming these Rorschach-like patterns into a structure requires some information about the shape of the protein. Tricks for getting this information, as well as other prediction tools, had failed. “The model from group 427 gave us our structure in half an hour, after we had spent a decade trying everything,” Lupas says." https://www.nature.com/articles/d41586-020-03348-4 https://www.nature.com/articles/d41586-020-03348-4 [2] (unconfirmed) https://twitter.com/halvorz/status/1417535090385580033 https://twitter.com/halvorz/status/1417535090385580033
- ramraj07 5y agoScientists themselves touted the HG project the same way. It's great and exciting but no one's curing cancer tomorrow. Just to clarify every researcher uses genome sequences every day as part of their research, so the human genome project did change how we do research as will this breakthrough. but It doesn't solve the real bottleneck problems that have prevented us from making real breakthroughs.
- drcode 5y agoIf we want to cure more cancers, we will eventually have to target drugs at the level of individual patient. Traditional animal models aren't going to work there. If medical ethicists in the US insist on requiring animal models into the indefinite future, cancer patients will have no options besides travelling to a foreign country to get their cancer treated.
- enkid 5y agoThe ability to rapidly sequence genes seems like it has been pretty revolutionary for medicine. Many cancers are treated based on their sequencing, and diseases are tracked through their genetic sequencing. For example, it's hard to imagine their being a lot of reporting on the variants of COVID before genetic sequencing was possible.